HUP1600436A2 - Salts for the preparation of a pharmaceutical composition - Google Patents
Salts for the preparation of a pharmaceutical compositionInfo
- Publication number
- HUP1600436A2 HUP1600436A2 HU1600436A HUP1600436A HUP1600436A2 HU P1600436 A2 HUP1600436 A2 HU P1600436A2 HU 1600436 A HU1600436 A HU 1600436A HU P1600436 A HUP1600436 A HU P1600436A HU P1600436 A2 HUP1600436 A2 HU P1600436A2
- Authority
- HU
- Hungary
- Prior art keywords
- salts
- preparation
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1600436A HUP1600436A2 (en) | 2016-07-14 | 2016-07-14 | Salts for the preparation of a pharmaceutical composition |
| PCT/HU2017/050028 WO2018011611A1 (en) | 2016-07-14 | 2017-07-14 | Salts for the production of pharmaceutical preparations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1600436A HUP1600436A2 (en) | 2016-07-14 | 2016-07-14 | Salts for the preparation of a pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP1600436A2 true HUP1600436A2 (en) | 2018-01-29 |
Family
ID=89992219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU1600436A HUP1600436A2 (en) | 2016-07-14 | 2016-07-14 | Salts for the preparation of a pharmaceutical composition |
Country Status (2)
| Country | Link |
|---|---|
| HU (1) | HUP1600436A2 (en) |
| WO (1) | WO2018011611A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10164139A1 (en) * | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-heteroaryl carboxamides |
| AU2011256287B2 (en) * | 2010-05-17 | 2016-11-10 | Envivo Pharmaceuticals, Inc. | A crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
| CN105601629A (en) * | 2015-02-02 | 2016-05-25 | 苏州晶云药物科技有限公司 | New crystal forms of (R)-7-chloro-N-(quinuclidinyl-3-yl)benzo[b]thienyl-2-formamide hydrochloride |
-
2016
- 2016-07-14 HU HU1600436A patent/HUP1600436A2/en not_active Application Discontinuation
-
2017
- 2017-07-14 WO PCT/HU2017/050028 patent/WO2018011611A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018011611A1 (en) | 2018-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL266017A (en) | Pharmaceutical compounds | |
| IL265360B (en) | Pharmaceutical composition | |
| GB201612092D0 (en) | Pharmaceutical compounds | |
| GB201617758D0 (en) | Pharmaceutical compounds | |
| IL265260B (en) | Pharmaceutical composition | |
| ZA201900540B (en) | Pharmaceutical compounds | |
| HUE052107T2 (en) | Pharmaceutical compounds | |
| IL265239A (en) | Process for the manufacture of a solid pharmaceutical composition | |
| IL262654A (en) | Pharmaceutical composition | |
| GB201612095D0 (en) | Pharmaceutical compounds | |
| GB201617454D0 (en) | Pharmaceutical compounds | |
| IL265349A (en) | Pharmaceutical composition | |
| GB201617871D0 (en) | Pharmaceutical compounds | |
| GB201615917D0 (en) | Pharmaceutical composition | |
| PT3632436T (en) | Pharmaceutical composition comprising lenvatinib salts | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| ZA201904033B (en) | Pharmaceutical compounds | |
| IL265436B (en) | Pharmaceutical composition | |
| HUP1600415A2 (en) | Pimavanserin salts for the manufacture of pharmaceutical formulations | |
| HK1232144A1 (en) | Pharmaceutical composition for oral administration | |
| GB201615912D0 (en) | Pharmaceutical compound | |
| GB201615916D0 (en) | Pharmaceutical compound | |
| HUP1600436A2 (en) | Salts for the preparation of a pharmaceutical composition | |
| IL265428A (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC4A | Lapse of provisional application due to refusal |